Drupal.behaviors.print = function(context) {window.print();window.close();}>
Q&A: What is the Impact of Myriad Patent Rulings on IP Landscape for Protein Biomarker-Based Tests?
August 19, 2011
Q&A: What is the Impact of Myriad Patent Rulings on IP Landscape for Protein Biomarker-Based Tests?
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Yale Researcher Suggests More Focus on EGFR Isoforms Needed in Development of Antibody-Based Drugs
May 20, 2011 / ProteoMonitor
Proteomics Expectations Bear Fruit in 2010, But Challenges Remain
January 7, 2011 / ProteoMonitor
NCI's Plan for Clinical Proteomics Initiative Spurs Questions about Sourcing of Patient Samples
August 27, 2010 / ProteoMonitor
People in the News: Eric Bouvier; Alan Marshall; and More
January 13, 2012 / ProteoMonitor
TGen's Center for Proteomics Named a Waters Center of Innovation
August 26, 2011 / ProteoMonitor